Literature DB >> 19337261

The comparative effectiveness challenge.

Bethan Hughes.   

Abstract

Mesh：

Year:  2009        PMID： 19337261     DOI： 10.1038/nrd2866

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  3 in total

1.  Report blames NICE for hastening decline of UK biotech.

Authors:  Nuala Moran
Journal:  Nat Biotechnol       Date:  2009-03       Impact factor: 54.908

2.  Comparative effectiveness casts first shadows across US industry.

Authors:  Emily Waltz
Journal:  Nat Biotechnol       Date:  2009-03       Impact factor: 54.908

Review 3.  Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers.

Authors:  Mark R Trusheim; Ernst R Berndt; Frank L Douglas
Journal:  Nat Rev Drug Discov       Date:  2007-04       Impact factor: 84.694
  3 in total
  4 in total

1.  2009 in reflection.

Authors: 
Journal:  Nat Rev Drug Discov       Date:  2010-01       Impact factor: 84.694

Review 2.  Relative efficacy of drugs: an emerging issue between regulatory agencies and third-party payers.

Authors:  Hans-Georg Eichler; Brigitte Bloechl-Daum; Eric Abadie; David Barnett; Franz König; Steven Pearson
Journal:  Nat Rev Drug Discov       Date:  2010-02-26       Impact factor: 84.694

3.  Alzheimer's disease: diagnostics, prognostics and the road to prevention.

Authors:  Iris Grossman; Michael W Lutz; Donna G Crenshaw; Ann M Saunders; Daniel K Burns; Allen D Roses
Journal:  EPMA J       Date:  2010-06-29       Impact factor: 6.543

Review 4.  Aligning the economic value of companion diagnostics and stratified medicines.

Authors:  Edward D Blair; Elyse K Stratton; Martina Kaufmann
Journal:  J Pers Med       Date:  2012-11-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.